NEW DELHI: India and Bangladesh have seen a spurt in bilateral engagement of late with gifts being exchanged across the border and also a series of meetings between top leaders of the two countries.
The spurt is being viewed by analysts as a way to reduce the friction seen in the ties due to India’s non-fulfilment of vaccine commitments. New Delhi has so far supplied around 103 lakh doses of Indian-made AstraZeneca vaccines—commercially and as a grant. However, as the second wave of the pandemic came, India forced the Serum Institute of India (SII), the manufacturer of vaccines in India, to defer orders.